A device for administering to a patient by inhaling through a nostril a measured quantity of powdered substance comprised of a concave spoon having a first end of a hollow tube attached thereto, the tube interior communicating to the spoon concavity, a flange having an aperture there through, the second end of the hollow tube attached to the flange and the hollow interior of the tube opening through the flange aperture.

Patent
   4216768
Priority
Mar 23 1978
Filed
Mar 23 1978
Issued
Aug 12 1980
Expiry
Mar 23 1998
Assg.orig
Entity
unknown
15
4
EXPIRED
1. A device for administering powdered medicinal substances by inhaling through a nostril comprised of planar flange means adatped to occlude a person's nostril opening having an aperture there through, a concave spoon, the spoon having a predetermined volume, a hollow tube, the tube having a first end mounted to the spoon, the hollow interior of the tube opening into the spoon concavity and the second end of the hollow tube mounted to the flange means, the hollow interior of the tube opening through the aperture in the flange means, whereby when the flange means is placed over a person's nostril, powdered substance placed in the spoon concavity may be readily inhaled through the hollow tube into the patient's nostril.
2. A device for administering to a person by inhaling through a nostril a measured quantity of powdered substance comprising and elongated hollow tube, the tube having an upper end and a lower end, an extended planar flange, means having a planar area adapted to occlude a person's nostril opening, the upper end of the tube mounted to the flange means, the hollow interior of tube opening extending through the flange means and opening on the upper surface thereof, a concave spoon, the lower end of the tube mounted onto the spoon and the hollow interior of the tube opening into the concavity of the spoon, whereby measured quantities of powdered substances placed in the spoon concavity may be administered directly through a person's nostril by placing the upper surface of the flange against a nostril which then closes the covered nostril except for the hollows tube opening when the person inhales.

The present invention relates to a device for administering measured quantities of powdered medicinals, snuff or the like by means of inhalation through the patient's or users nostril.

Various medicinal materials as well as snuff and like substances are best administered to the patient, or user, in controlled quantities of fine powder inhaled through the nostril and placed in direct contact with the patient's upper respiratory system surfaces.

Various spray means have been devised to administer vaporized and atomized droplets of liquid medicinals through the patient's respiratory system by nostril inhalation of vapor or droplets. However, numerous medicinal materials useful for treating respiratory system discomfort or disease are best preserved and most effectively administered as fine powdered dust inhaled through the patient's nostrils. Simple effective means to administer dry powdered inhalant to the patient's respiratory surfaces has heretofore been lacking. Those powder inhalant devices that were available lacked simplicity of design and ease of use. Those dry powder inhaler devices heretofor described required several parts to be disassembled and then reassembled by the user to utilize the device.

There remained the need for a simple effective and inexpensive device to administer measured quantities of powdered substance by nasal inhalation.

Accordingly, one object of my invention is to provide a simple effective device for administering powdered inhalant material.

Another object of my invention is to provide a simple device for measuring a controlled quantity of dry powdered substance and administering the substance through nasal inhalation.

A device for administering a measured quantity of a powdered substance to a person by nasal inhalation comprised of a flange having an aperture there through for covering one nostril, a hollow tube the first end of which is connected to the flange, the hollow interior of the tube opening through the flange aperture, a concave spoon, the second end of the hollow tube being connected to the spoon, the hollow interior thereof opening into the spoon concavity, whereby measured quantities of powdered substances placed in the spoon concavity may be administered through a patient's nostril.

FIG. 1 is a perspective view of a preferred embodiment of my invention.

FIG. 2 is a cross section elevation view of the embodiment of my invention shown in FIG. 1.

A preferred embodiment of my invention comprising an instrument for administering a measured quantity of powdered substance to a patient through one nostril is illustrated in FIG. 1.

A hollow spoon 10 is mounted to the lower end of an elongated tube 12. The tube 12 is provided with an axial channel or opening 14 passing there through. The lower end of the axial opening 14 of the tube connects to the concave hollow spoon 10.

A flange 16 is mounted to the upper end of the tube 12. An aperture 18 in the upper surface of the flange 16 connects to the axial channel 14 of the elongated tube. Thus, an open channel between the interior or concave portion of the spoon 10 is provided which connects through the elongated tube 12 and into the flange aperture 18.

FIG. 2, a vertical cross section view of the instrument, clearly illustrates the arrangement of the air passage and component parts of the invention described above. To use the device a patient places the flange 16 over one nostril, holding the other nostril closed. The patient then inhales, sucking through his nostril, whatever powdered substance had previously been placed in the concave spoon 10.

the spoon 10 has a measured volume within its concave cavity within which powdered inhalant substances may be placed. The volume of the spoon concavity may conveniently be for instance, one-eighth or one-fourth cubic centimeter. Thus, the medicinal dosage can be readily judged by leveling the powdered inhalant with the rim of the hollow spoon.

My inhalant administration device may be made preferrably of a corrosion resistant metal, such as aluminum, stainless steel, silver or other metal. The metal surface may be plated to increase corrosion resistance. The device may also be conveniently made of plastic or other easily molded or machined material.

The foregoing specification and description is illustrative of my invention, the scope of which is defined in the following claims.

Jack, Whitfield

Patent Priority Assignee Title
10441733, Jun 25 2012 RESPIRA THERAPEUTICS, INC Powder dispersion devices and methods
11471623, Feb 21 2012 Respira Therapeutics, Inc. Powder dispersion methods and devices
5042472, Oct 15 1990 Merck & Co., Inc.; MERCK & CO , INC A CORPORATION OF NEW JERSEY Powder inhaler device
6116239, Aug 07 1997 SLUTSKY, ART; ZAMEL, NOE; VOLGYESI, GEORGE Inhalation device
6575160, Aug 07 1997 Art, Slutsky; Noe, Zamel; George, Volgyesi Inhalation device
6648848, May 27 1997 ACERUS BIOPHARMA INC Inhaler for powdered medicaments
6811543, May 27 1997 ACERUS BIOPHARMA INC Method for introducing a powdered substance into a nostril
8327844, Mar 03 1999 OPTINOSE INC Nasal delivery method
8555877, Mar 03 1999 OPTINOSE INC Nasal delivery device
8555878, Mar 03 1999 OPTINOSE INC Nasal delivery device
8561609, Dec 07 2010 RESPIRA THERAPEUTICS, INC Dry powder inhaler
8651104, Dec 07 2010 RESPIRA THERAPEUTICS, INC Bead-containing dry powder inhaler
9072857, Mar 03 1999 OPTINOSE INC Nasal delivery device
9119932, Mar 03 1999 OPTINOSE INC Nasal delivery device
9492625, Nov 12 2009 STC UNM Dry powder inhaler with flutter dispersion member
Patent Priority Assignee Title
1200490,
214617,
620792,
DE217663,
Executed onAssignorAssigneeConveyanceFrameReelDoc
Date Maintenance Fee Events


Date Maintenance Schedule
Aug 12 19834 years fee payment window open
Feb 12 19846 months grace period start (w surcharge)
Aug 12 1984patent expiry (for year 4)
Aug 12 19862 years to revive unintentionally abandoned end. (for year 4)
Aug 12 19878 years fee payment window open
Feb 12 19886 months grace period start (w surcharge)
Aug 12 1988patent expiry (for year 8)
Aug 12 19902 years to revive unintentionally abandoned end. (for year 8)
Aug 12 199112 years fee payment window open
Feb 12 19926 months grace period start (w surcharge)
Aug 12 1992patent expiry (for year 12)
Aug 12 19942 years to revive unintentionally abandoned end. (for year 12)